nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0353	0.0555	CcSEcCtD
Irinotecan—Intestinal obstruction—Varenicline—nicotine dependence	0.0254	0.0399	CcSEcCtD
Irinotecan—Thrombosis—Varenicline—nicotine dependence	0.0245	0.0385	CcSEcCtD
Irinotecan—Accidental injury—Varenicline—nicotine dependence	0.0196	0.0308	CcSEcCtD
Irinotecan—Lacrimation increased—Varenicline—nicotine dependence	0.0188	0.0295	CcSEcCtD
Irinotecan—Dysarthria—Varenicline—nicotine dependence	0.0183	0.0288	CcSEcCtD
Irinotecan—Pulmonary embolism—Varenicline—nicotine dependence	0.0173	0.0272	CcSEcCtD
Irinotecan—Salivary hypersecretion—Varenicline—nicotine dependence	0.0168	0.0264	CcSEcCtD
Irinotecan—TOP1MT—brain—nicotine dependence	0.0148	0.101	CbGeAlD
Irinotecan—CES2—cardiovascular system—nicotine dependence	0.0145	0.0984	CbGeAlD
Irinotecan—Injury—Varenicline—nicotine dependence	0.0137	0.0215	CcSEcCtD
Irinotecan—Renal failure acute—Varenicline—nicotine dependence	0.0136	0.0214	CcSEcCtD
Irinotecan—Visual disturbance—Varenicline—nicotine dependence	0.0133	0.0209	CcSEcCtD
Irinotecan—CYP2B6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0132	0.0606	CbGpPWpGaD
Irinotecan—Cerebrovascular accident—Varenicline—nicotine dependence	0.0128	0.0202	CcSEcCtD
Irinotecan—Osteoarthritis—Varenicline—nicotine dependence	0.0126	0.0198	CcSEcCtD
Irinotecan—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0126	0.0198	CcSEcCtD
Irinotecan—TOP1—midbrain—nicotine dependence	0.0124	0.0847	CbGeAlD
Irinotecan—CES2—E2F transcription factor network—WASF1—nicotine dependence	0.0123	0.0566	CbGpPWpGaD
Irinotecan—CES1—cardiovascular system—nicotine dependence	0.0119	0.081	CbGeAlD
Irinotecan—Hypokalaemia—Varenicline—nicotine dependence	0.0114	0.018	CcSEcCtD
Irinotecan—Cramp muscle—Varenicline—nicotine dependence	0.0113	0.0178	CcSEcCtD
Irinotecan—CES2—midbrain—nicotine dependence	0.0113	0.0769	CbGeAlD
Irinotecan—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.011	0.0508	CbGpPWpGaD
Irinotecan—Abdominal distension—Varenicline—nicotine dependence	0.0109	0.0172	CcSEcCtD
Irinotecan—Angina pectoris—Varenicline—nicotine dependence	0.0106	0.0166	CcSEcCtD
Irinotecan—CYP2B6—Fatty acids—CYP2A7—nicotine dependence	0.0103	0.0473	CbGpPWpGaD
Irinotecan—Acute coronary syndrome—Varenicline—nicotine dependence	0.00954	0.015	CcSEcCtD
Irinotecan—Myocardial infarction—Varenicline—nicotine dependence	0.00949	0.0149	CcSEcCtD
Irinotecan—Stomatitis—Varenicline—nicotine dependence	0.00944	0.0148	CcSEcCtD
Irinotecan—ACHE—midbrain—nicotine dependence	0.00929	0.0633	CbGeAlD
Irinotecan—Bradycardia—Varenicline—nicotine dependence	0.00885	0.0139	CcSEcCtD
Irinotecan—Connective tissue disorder—Varenicline—nicotine dependence	0.00854	0.0134	CcSEcCtD
Irinotecan—Visual impairment—Varenicline—nicotine dependence	0.00838	0.0132	CcSEcCtD
Irinotecan—CYP2B6—Xenobiotics—CYP2A7—nicotine dependence	0.00816	0.0375	CbGpPWpGaD
Irinotecan—Cardiac disorder—Varenicline—nicotine dependence	0.00807	0.0127	CcSEcCtD
Irinotecan—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00798	0.0367	CbGpPWpGaD
Irinotecan—Angiopathy—Varenicline—nicotine dependence	0.00788	0.0124	CcSEcCtD
Irinotecan—Immune system disorder—Varenicline—nicotine dependence	0.00785	0.0123	CcSEcCtD
Irinotecan—Mediastinal disorder—Varenicline—nicotine dependence	0.00783	0.0123	CcSEcCtD
Irinotecan—TOP1—brain—nicotine dependence	0.00782	0.0532	CbGeAlD
Irinotecan—Chills—Varenicline—nicotine dependence	0.0078	0.0123	CcSEcCtD
Irinotecan—Arrhythmia—Varenicline—nicotine dependence	0.00776	0.0122	CcSEcCtD
Irinotecan—Flatulence—Varenicline—nicotine dependence	0.00745	0.0117	CcSEcCtD
Irinotecan—Back pain—Varenicline—nicotine dependence	0.00732	0.0115	CcSEcCtD
Irinotecan—Muscle spasms—Varenicline—nicotine dependence	0.00727	0.0114	CcSEcCtD
Irinotecan—CES1—E2F transcription factor network—WASF1—nicotine dependence	0.00725	0.0334	CbGpPWpGaD
Irinotecan—CES2—brain—nicotine dependence	0.00709	0.0483	CbGeAlD
Irinotecan—Ill-defined disorder—Varenicline—nicotine dependence	0.00702	0.011	CcSEcCtD
Irinotecan—Anaemia—Varenicline—nicotine dependence	0.00699	0.011	CcSEcCtD
Irinotecan—Malaise—Varenicline—nicotine dependence	0.00682	0.0107	CcSEcCtD
Irinotecan—Vertigo—Varenicline—nicotine dependence	0.0068	0.0107	CcSEcCtD
Irinotecan—Syncope—Varenicline—nicotine dependence	0.00678	0.0107	CcSEcCtD
Irinotecan—Loss of consciousness—Varenicline—nicotine dependence	0.00665	0.0105	CcSEcCtD
Irinotecan—Cough—Varenicline—nicotine dependence	0.0066	0.0104	CcSEcCtD
Irinotecan—Hypertension—Varenicline—nicotine dependence	0.00653	0.0103	CcSEcCtD
Irinotecan—Discomfort—Varenicline—nicotine dependence	0.00636	0.01	CcSEcCtD
Irinotecan—Oedema—Varenicline—nicotine dependence	0.00617	0.00971	CcSEcCtD
Irinotecan—Infection—Varenicline—nicotine dependence	0.00613	0.00965	CcSEcCtD
Irinotecan—Shock—Varenicline—nicotine dependence	0.00607	0.00955	CcSEcCtD
Irinotecan—Nervous system disorder—Varenicline—nicotine dependence	0.00606	0.00952	CcSEcCtD
Irinotecan—Thrombocytopenia—Varenicline—nicotine dependence	0.00605	0.00951	CcSEcCtD
Irinotecan—Hyperhidrosis—Varenicline—nicotine dependence	0.00597	0.00939	CcSEcCtD
Irinotecan—TOP1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00591	0.0272	CbGpPWpGaD
Irinotecan—Anorexia—Varenicline—nicotine dependence	0.00589	0.00926	CcSEcCtD
Irinotecan—BCHE—cardiovascular system—nicotine dependence	0.00585	0.0398	CbGeAlD
Irinotecan—ACHE—brain—nicotine dependence	0.00584	0.0398	CbGeAlD
Irinotecan—CES1—brain—nicotine dependence	0.00584	0.0398	CbGeAlD
Irinotecan—Hypotension—Varenicline—nicotine dependence	0.00577	0.00907	CcSEcCtD
Irinotecan—Insomnia—Varenicline—nicotine dependence	0.00558	0.00878	CcSEcCtD
Irinotecan—Dyspnoea—Varenicline—nicotine dependence	0.0055	0.00866	CcSEcCtD
Irinotecan—Somnolence—Varenicline—nicotine dependence	0.00549	0.00863	CcSEcCtD
Irinotecan—Dyspepsia—Varenicline—nicotine dependence	0.00544	0.00855	CcSEcCtD
Irinotecan—Decreased appetite—Varenicline—nicotine dependence	0.00537	0.00844	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00533	0.00838	CcSEcCtD
Irinotecan—Fatigue—Varenicline—nicotine dependence	0.00532	0.00837	CcSEcCtD
Irinotecan—Constipation—Varenicline—nicotine dependence	0.00528	0.0083	CcSEcCtD
Irinotecan—Pain—Varenicline—nicotine dependence	0.00528	0.0083	CcSEcCtD
Irinotecan—CYP2B6—cardiovascular system—nicotine dependence	0.00522	0.0355	CbGeAlD
Irinotecan—Feeling abnormal—Varenicline—nicotine dependence	0.00509	0.008	CcSEcCtD
Irinotecan—Gastrointestinal pain—Varenicline—nicotine dependence	0.00505	0.00794	CcSEcCtD
Irinotecan—Abdominal pain—Varenicline—nicotine dependence	0.00488	0.00768	CcSEcCtD
Irinotecan—Body temperature increased—Varenicline—nicotine dependence	0.00488	0.00768	CcSEcCtD
Irinotecan—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00458	0.0211	CbGpPWpGaD
Irinotecan—BCHE—midbrain—nicotine dependence	0.00457	0.0311	CbGeAlD
Irinotecan—Hypersensitivity—Varenicline—nicotine dependence	0.00455	0.00716	CcSEcCtD
Irinotecan—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00452	0.0208	CbGpPWpGaD
Irinotecan—Asthenia—Varenicline—nicotine dependence	0.00443	0.00697	CcSEcCtD
Irinotecan—ABCG2—midbrain—nicotine dependence	0.00442	0.0301	CbGeAlD
Irinotecan—TOP1—Circadian rythm related genes—DRD2—nicotine dependence	0.00437	0.0201	CbGpPWpGaD
Irinotecan—Diarrhoea—Varenicline—nicotine dependence	0.00422	0.00664	CcSEcCtD
Irinotecan—Dizziness—Varenicline—nicotine dependence	0.00408	0.00642	CcSEcCtD
Irinotecan—ALB—brain—nicotine dependence	0.00406	0.0276	CbGeAlD
Irinotecan—SLC22A3—brain—nicotine dependence	0.00405	0.0276	CbGeAlD
Irinotecan—Vomiting—Varenicline—nicotine dependence	0.00393	0.00617	CcSEcCtD
Irinotecan—Rash—Varenicline—nicotine dependence	0.00389	0.00612	CcSEcCtD
Irinotecan—Dermatitis—Varenicline—nicotine dependence	0.00389	0.00612	CcSEcCtD
Irinotecan—Headache—Varenicline—nicotine dependence	0.00387	0.00608	CcSEcCtD
Irinotecan—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00371	0.0171	CbGpPWpGaD
Irinotecan—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00371	0.0171	CbGpPWpGaD
Irinotecan—Nausea—Varenicline—nicotine dependence	0.00367	0.00577	CcSEcCtD
Irinotecan—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00339	0.0156	CbGpPWpGaD
Irinotecan—ABCC1—brain—nicotine dependence	0.00335	0.0228	CbGeAlD
Irinotecan—CYP2B6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00334	0.0154	CbGpPWpGaD
Irinotecan—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00331	0.0152	CbGpPWpGaD
Irinotecan—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00327	0.015	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0032	0.0147	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00303	0.0139	CbGpPWpGaD
Irinotecan—BCHE—brain—nicotine dependence	0.00287	0.0195	CbGeAlD
Irinotecan—BCHE—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00285	0.0131	CbGpPWpGaD
Irinotecan—ABCB1—cardiovascular system—nicotine dependence	0.00279	0.019	CbGeAlD
Irinotecan—ABCG2—brain—nicotine dependence	0.00277	0.0189	CbGeAlD
Irinotecan—CYP2B6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00275	0.0126	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0027	0.0124	CbGpPWpGaD
Irinotecan—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00269	0.0124	CbGpPWpGaD
Irinotecan—CYP2B6—brain—nicotine dependence	0.00256	0.0174	CbGeAlD
Irinotecan—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00249	0.0115	CbGpPWpGaD
Irinotecan—UGT1A9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00249	0.0115	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—CHRNB3—nicotine dependence	0.00245	0.0113	CbGpPWpGaD
Irinotecan—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00235	0.0108	CbGpPWpGaD
Irinotecan—UGT1A9—Biological oxidations—CYP2A7—nicotine dependence	0.00235	0.0108	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—CHRNA6—nicotine dependence	0.00232	0.0107	CbGpPWpGaD
Irinotecan—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00231	0.0106	CbGpPWpGaD
Irinotecan—UGT1A9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00231	0.0106	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00219	0.0101	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—CHRNB3—nicotine dependence	0.00219	0.0101	CbGpPWpGaD
Irinotecan—ABCB1—midbrain—nicotine dependence	0.00218	0.0148	CbGeAlD
Irinotecan—ACHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.0021	0.00967	CbGpPWpGaD
Irinotecan—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00209	0.00963	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—CHRNA6—nicotine dependence	0.00207	0.00953	CbGpPWpGaD
Irinotecan—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00197	0.00908	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00196	0.009	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00195	0.00899	CbGpPWpGaD
Irinotecan—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00195	0.00895	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00187	0.00862	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00174	0.00802	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—GABRA4—nicotine dependence	0.00168	0.00773	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—CHRNB4—nicotine dependence	0.00161	0.00741	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00159	0.00733	CbGpPWpGaD
Irinotecan—CYP2B6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00155	0.00712	CbGpPWpGaD
Irinotecan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00154	0.00709	CbGpPWpGaD
Irinotecan—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00152	0.00699	CbGpPWpGaD
Irinotecan—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00151	0.00696	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—GABRA4—nicotine dependence	0.0015	0.00689	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—CHRNA5—nicotine dependence	0.0015	0.00689	CbGpPWpGaD
Irinotecan—CYP2B6—Biological oxidations—CYP2A7—nicotine dependence	0.00146	0.00671	CbGpPWpGaD
Irinotecan—CYP2B6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00144	0.00662	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—CHRNB4—nicotine dependence	0.00144	0.00661	CbGpPWpGaD
Irinotecan—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00143	0.00656	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00142	0.00654	CbGpPWpGaD
Irinotecan—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00141	0.00647	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.0014	0.00645	CbGpPWpGaD
Irinotecan—ABCB1—brain—nicotine dependence	0.00137	0.00931	CbGeAlD
Irinotecan—BCHE—Neuronal System—CHRNA5—nicotine dependence	0.00134	0.00614	CbGpPWpGaD
Irinotecan—ACHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00127	0.00586	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00125	0.00575	CbGpPWpGaD
Irinotecan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00125	0.00574	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—CHRNA3—nicotine dependence	0.00122	0.00561	CbGpPWpGaD
Irinotecan—SLC22A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00115	0.00528	CbGpPWpGaD
Irinotecan—BCHE—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00114	0.00523	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—CHRNA3—nicotine dependence	0.00109	0.00501	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—CHRNB2—nicotine dependence	0.00107	0.00494	CbGpPWpGaD
Irinotecan—ACHE—Neuronal System—CHRNA4—nicotine dependence	0.000975	0.00449	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—CHRNB2—nicotine dependence	0.000958	0.00441	CbGpPWpGaD
Irinotecan—BCHE—Neuronal System—CHRNA4—nicotine dependence	0.00087	0.004	CbGpPWpGaD
Irinotecan—ABCC2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000836	0.00385	CbGpPWpGaD
Irinotecan—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000826	0.0038	CbGpPWpGaD
Irinotecan—SLCO1B1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000785	0.00361	CbGpPWpGaD
Irinotecan—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000727	0.00334	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000704	0.00324	CbGpPWpGaD
Irinotecan—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000663	0.00305	CbGpPWpGaD
Irinotecan—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000654	0.00301	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—CYP2A7—nicotine dependence	0.000537	0.00247	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKR1B10—nicotine dependence	0.000497	0.00229	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000449	0.00206	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—CYP2A7—nicotine dependence	0.000423	0.00195	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CYP2A7—nicotine dependence	0.000401	0.00185	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CYP2A7—nicotine dependence	0.000401	0.00185	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000393	0.00181	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.000387	0.00178	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CYP2A7—nicotine dependence	0.000377	0.00174	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CYP2A7—nicotine dependence	0.000368	0.00169	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.00034	0.00157	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000337	0.00155	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP2A7—nicotine dependence	0.00025	0.00115	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000244	0.00112	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP2A7—nicotine dependence	0.00021	0.000967	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000184	0.000847	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000113	0.000522	CbGpPWpGaD
